For: | Fiorino S, Bacchi-Reggiani L, de Biase D, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Acquaviva G, di Tommaso L, Bondi A, Visani M, Sabbatani S, Pontoriero L, Fabbri C, Cuppini A, Pession A, Jovine E. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World J Gastroenterol 2015; 21(45): 12896-12953 [PMID: 26668515 DOI: 10.3748/wjg.v21.i45.12896] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i45/12896.htm |
Number | Citing Articles |
1 |
Juliana de Brito Rangel, Luiz Claudio Santos Thuler, Jorge Francisco da Cunha Pinto. Prevalence of hepatitis C virus infection and its impact on the prognosis of head and neck cancer patients. Oral Oncology 2018; 87: 138 doi: 10.1016/j.oraloncology.2018.10.024
|
2 |
Federica Di Spirito, Maria Pia Di Palo, Veronica Folliero, Davide Cannatà, Gianluigi Franci, Stefano Martina, Massimo Amato. Oral Bacteria, Virus and Fungi in Saliva and Tissue Samples from Adult Subjects with Oral Squamous Cell Carcinoma: An Umbrella Review. Cancers 2023; 15(23): 5540 doi: 10.3390/cancers15235540
|
3 |
Wangjun Zhang, Fan Xiao, Jie Li, Xiaoyu Guo, Zhitao Lin, Zijian Huang, Ning Mao, Bei Sun, Gang Wang. Rare heterochronous liver and pancreatic multiple primary cancers: a case report and literature review. Zeitschrift für Gastroenterologie 2020; 58(11): 1094 doi: 10.1055/a-1160-6082
|
4 |
Yuichi Honma, Michihiko Shibata, Kahori Morino, Yudai Koya, Tsuguru Hayashi, Noriyoshi Ogino, Masashi Kusanaga, Shinji Oe, Koichiro Miyagawa, Shintaro Abe, Akinari Tabaru, Masaru Harada. Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C. Digestive Diseases and Sciences 2023; 68(2): 685 doi: 10.1007/s10620-022-07686-3
|
5 |
Sara Donà, Daniele Borsetto, Jonathan Fussey, Valeria Biscaro, Elisa Vian, Giacomo Spinato, Anna Menegaldo, Maria Cristina Da Mosto, Roberto Rigoli, Jerry Polesel, Paolo Boscolo-Rizzo. Association between hepatitis C and B viruses and head and neck squamous cell carcinoma. Journal of Clinical Virology 2019; 121: 104209 doi: 10.1016/j.jcv.2019.104209
|
6 |
Dalia Y Kadry, Mostafa A Elbahnasawy, Mohamed TM Mansour, Omnia K EL Gebaly, Hala Aziz, Mahmoud M Kamel, Ahmed S Abdel-Moneim, Samah Radwan. The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin’s lymphoma. International Journal of Immunopathology and Pharmacology 2023; 37 doi: 10.1177/03946320231207342
|
7 |
Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, Roberta Budriesi, Matteo Micucci, Michela Visani, Elisabetta Loggi, Wandong Hong, Roberta Pica, Federico Lari, Maddalena Zippi. Sars-CoV-2: Lessons from Both the History of Medicine and from the Biological Behavior of Other Well-Known Viruses. Future Microbiology 2021; 16(14): 1105 doi: 10.2217/fmb-2021-0064
|
8 |
Mitchell L. Shiffman, Nadege T. Gunn. Impact of hepatitis C virus therapy on metabolism and public health. Liver International 2017; 37(S1): 13 doi: 10.1111/liv.13282
|
9 |
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and Pathogenesis. Journal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
|
10 |
Teresa Rojas Rojas, Isabelle Poizot-Martin, David Rey, Claudine Duvivier, Firouzé Bani-Sadr, André Cabie, Pierre Delobel, Christine Jacomet, Clotilde Allavena, Tristan Ferry, Pascal Pugliese, Marc-Antoine Valantin, Isabelle Lamaury, Laurent Hustache-Matthieu, Anne Fresard, Tamazighth Houyou, Thomas Huleux, Antoine Cheret, Alain Makinson, Véronique Obry-Roguet, Caroline Lions, Maria Patrizia Carrieri, Camelia Protopopescu, Cristian Apetrei. Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France. PLOS ONE 2022; 17(3): e0261069 doi: 10.1371/journal.pone.0261069
|
11 |
Daniele Borsetto, Jonathan Fussey, Luca Fabris, Luigia Bandolin, Piergiorgio Gaudioso, Veronica Phillips, Jerry Polesel, Paolo Boscolo-Rizzo. HCV infection and the risk of head and neck cancer: A meta-analysis. Oral Oncology 2020; 109: 104869 doi: 10.1016/j.oraloncology.2020.104869
|
12 |
Amy L. Pashler, Benjamin P. Towler, Christopher I. Jones, Sarah F. Newbury. The roles of the exoribonucleases DIS3L2 and XRN1 in human disease. Biochemical Society Transactions 2016; 44(5): 1377 doi: 10.1042/BST20160107
|
13 |
Iván Herrera, Susana Almenara, Pablo Bellot, Cayetano Miralles, Maria Rodriguez, Lucia Gómez-González, José M. Palazón, Sonia Pascual, Pedro Zapater. Tobacco is a Leading Risk Factor for Liver and Extrahepatic Cancers in Patients With Liver Cirrhosis: A Prospective Cohort Study. Journal of Clinical and Experimental Hepatology 2024; 14(6): 101472 doi: 10.1016/j.jceh.2024.101472
|
14 |
Subhayan Das, Moumita Kundu, Bikash Chandra Jena, Mahitosh Mandal. Biomaterials for 3D Tumor Modeling. 2020; : 607 doi: 10.1016/B978-0-12-818128-7.00025-3
|
15 |
A S Samoylov, A Yu Bushmanov, Yu D Udalov, I A Galstyan, V Yu Nugis, M G Kozlova, V A Nikitina, I K Khvostunov, E V Golub. ACUTE MYELOID LEUKEMIA, PROSTATE AND SKIN CANCER IN ACUTE RADIATION SYNDROME SURVIVOR AFTER THE 1986 CHERNOBYL NUCLEAR ACCIDENT: CASE REPORT. Radiation Protection Dosimetry 2018; 182(1): 85 doi: 10.1093/rpd/ncy143
|
16 |
Manon Allaire, Pierre Nahon, Richard Layese, Valérie Bourcier, Carole Cagnot, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean‐Pierre Bronowicki, Jean‐Pierre Zarski, Ghassan Riachi, Paul Calès, Jean‐Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Jean‐Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean‐Didier Grangé, Pierre Attali, Yannick Bacq, Claire Wartelle, Thông Dao, Dominique Thabut, Christophe Pilette, Christine Silvain, Christos Christidis, Eric Nguyen‐Khac, Brigitte Bernard‐Chabert, David Zucman, Vincent DI Martino, Angela Sutton, Eric Letouzé, Etienne Audureau, Françoise Roudot‐Thoraval. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. Hepatology 2018; 68(4): 1245 doi: 10.1002/hep.30034
|
17 |
Joaquin Burgos, Adria Curran, Stefania Landolfi, Ana Guelar, Lucia Miguel, MaCarmen Dinares, Judith Villar, Jordi Navarro, Javier Hernandez-Losa, Vicenç Falcó. Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected MSM. AIDS 2017; 31(9): 1245 doi: 10.1097/QAD.0000000000001433
|
18 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy. World Journal of Gastrointestinal Oncology 2021; 13(10): 1229-1243 doi: 10.4251/wjgo.v13.i10.1229
|
19 |
Di Sun, Min Ding, Mengfan Ruan, Li Yang, Xingshun Qi. Hepatitis C - Recent Advances. 2023; doi: 10.5772/intechopen.1001335
|
20 |
Romeo-Gabriel Mihăilă. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma. World Journal of Gastroenterology 2016; 22(27): 6214-6223 doi: 10.3748/wjg.v22.i27.6214
|
21 |
A. Rivero-Juarez, L. F. Lopez-Cortes, M. Castaño, D. Merino, M. Marquez, M. Mancebo, F. Cuenca-Lopez, P. Jimenez-Aguilar, I. Lopez-Montesinos, S. Lopez-Cardenas, A. Collado, M. A. Lopez-Ruz, M. Omar, F. Tellez, X. Perez-Stachowski, J. Hernandez-Quero, J. A. Girón-Gonzalez, E. Fernandez-Fuertes, A. Rivero. Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy. European Journal of Clinical Microbiology & Infectious Diseases 2017; 36(3): 487 doi: 10.1007/s10096-016-2822-6
|
22 |
JUR-SHAN Cheng, TSE-CHING CHEN, TAI-DI CHEN, HSIN-PING KU, SHU-WEI HUANG, TING-SHU WU, RONG-NAN CHIEN, MING-LING CHANG. Association between breast cancer and hepatitis C: A joint study of hospitalized patients and nationwide cohorts. Translational Research 2022; 245: 117 doi: 10.1016/j.trsl.2022.02.009
|
23 |
Zong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, Kuan-Yu Chen, Jin-Yuan Shih, Jin-Shing Chen, Zhong-Zhe Lin, Chia-Chi Lin, James Chih-Hsin Yang, Chong-Jen Yu. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib. The Oncologist 2017; 22(9): 1075 doi: 10.1634/theoncologist.2016-0331
|
24 |
L. Couronné, E. Bachy, S. Roulland, B. Nadel, F. Davi, M. Armand, D. Canioni, J.M. Michot, C. Visco, L. Arcaini, C. Besson, O. Hermine. From hepatitis C virus infection to B-cell lymphoma. Annals of Oncology 2018; 29(1): 92 doi: 10.1093/annonc/mdx635
|
25 |
Mariya A. Derbak, Olha V. Buchok, Taras M. Ganich, Mariya V. Rivis, Yana V. Lazur, Viktoriya M. Polyak-Tovt, Volodymyr V. Timashev. PECULIARITIES OF THE FUNCTIONAL STATE OF THE LIVER IN PATIENTS WITH CHRONIC HEPATITIS C IN THE PRESENCE OF CHRONIC PANCREATITIS. Wiadomości Lekarskie 2023; 76(11): 2359 doi: 10.36740/WLek202311103
|
26 |
Donald M. Parkin, Lucia Hämmerl, Jacques Ferlay, Eva J. Kantelhardt. Cancer in Africa 2018: The role of infections. International Journal of Cancer 2020; 146(8): 2089 doi: 10.1002/ijc.32538
|
27 |
|
28 |
Yusha Yang, Zufu Jiang, Weizhou Wu, Libin Ruan, Chengyang Yu, Yuning Xi, Liling Wang, Kunpeng Wang, Jinggang Mo, Shankun Zhao. Chronic Hepatitis Virus Infection Are Associated With High Risk of Gastric Cancer: A Systematic Review and Cumulative Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.703558
|
29 |
George N. Ioannou, Pamela K. Green, Kristin Berry, Solomon A. Graf. Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct‐Acting Antivirals. Hepatology Communications 2019; 3(8): 1124 doi: 10.1002/hep4.1389
|
30 |
Nader N. Massarweh, Hashem B. El-Serag. Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control 2017; 24(3): 107327481772924 doi: 10.1177/1073274817729245
|
31 |
Osama Hussein, Engy Mohamed El-Ghitany, Mawadda Omran, Ghadier Matariek, Esraa Ahmed Elbadaly, Rana Hamdy, Amira Gamal, Mai Mohamed Zayed, Ahmed Nasr, Omar Hamdy, Mohamed Elbasiony, Khaled Abdelwahab. High Seroprevalence of Hepatitis C Virus Antibody in Breast Cancer Patients in Egypt. Breast Cancer: Basic and Clinical Research 2021; 15: 117822342110024 doi: 10.1177/11782234211002499
|
32 |
Elisa Barone, Alda Corrado, Federica Gemignani, Stefano Landi. Environmental risk factors for pancreatic cancer: an update. Archives of Toxicology 2016; 90(11): 2617 doi: 10.1007/s00204-016-1821-9
|
33 |
H.O. Khomyn, L.S. Babinets, I.M. Halabitska. Assessment of morphological changes in the gastroduodenal area of patients with chronic pancreatitis in comorbidity with chronic viral hepatitis C. GASTROENTEROLOGY 2023; 57(2): 70 doi: 10.22141/2308-2097.57.2.2023.534
|
34 |
Di Wu, Shiping Hu, Guozi Chen, Longjiao Chen, Jian Liu, Wenlin Chen, Youwen Lv, Xiaoni Chen, Shan Lin, Fenfang Wu. Association of hepatitis C infection and risk of kidney cancer: A systematic review and meta‐analysis of observational studies. Journal of Viral Hepatitis 2021; 28(2): 226 doi: 10.1111/jvh.13434
|
35 |
Charlotte Leduc, Delphine Antoni, Anne Charloux, Pierre-Emmanuel Falcoz, Elisabeth Quoix. Comorbidities in the management of patients with lung cancer. European Respiratory Journal 2017; 49(3): 1601721 doi: 10.1183/13993003.01721-2016
|
36 |
Stanislas Pol, Anaïs Vallet-Pichard, Olivier Hermine. Extrahepatic cancers and chronic HCV infection. Nature Reviews Gastroenterology & Hepatology 2018; 15(5): 283 doi: 10.1038/nrgastro.2017.172
|
37 |
Abdelfattah M. Attallah, Mohamed El-Far, Mohamed A. Abdelrazek, Mohamed M. Omran, Ashraf Z. Mahmoud, Hager S. Khalifa, Mohamed M. Ahmed, Ibrahim El-Dosoky. HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer. Breast Cancer 2018; 25(3): 297 doi: 10.1007/s12282-017-0829-1
|
38 |
Teresa Pollicino, Cristina Musolino, Carlo Saitta, Gianluca Tripodi, Marika Lanza, Giuseppina Raffa, Francesca Casuscelli di Tocco, Chiara Raggi, Maria Consiglia Bragazzi, Adalberto Barbera, Giuseppe Navarra, Pietro Invernizzi, Domenico Alvaro, Giovanni Raimondo. Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma. Oncotarget 2019; 10(39): 3931 doi: 10.18632/oncotarget.27002
|
39 |
Harrys A. Torres, Terri Lynn Shigle, Nassim Hammoudi, James T. Link, Felipe Samaniego, Ahmed Kaseb, Vincent Mallet. The oncologic burden of hepatitis C virus infection: A clinical perspective. CA: A Cancer Journal for Clinicians 2017; 67(5): 411 doi: 10.3322/caac.21403
|
40 |
Tarek Saadi, Johad Khoury. Is There a Relationship Between Treatment With Direct Antiviral Agents for HCV Infection and the Development of Malignancies?. Journal of Clinical Gastroenterology 2018; 52(4): 353 doi: 10.1097/MCG.0000000000000853
|
41 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_94-1
|
42 |
Yin-Yi Chu, Jur-Shan Cheng, Ting-Shu Wu, Chun-Wei Chen, Ming-Yu Chang, Hsin-Ping Ku, Rong-Nan Chien, Ming-Ling Chang. Association between Hepatitis C Virus Infection and Esophageal Cancer: An Asian Nationwide Population-Based Cohort Study. Journal of Clinical Medicine 2021; 10(11): 2395 doi: 10.3390/jcm10112395
|
43 |
Shuntaro Obi, Miho Kanda, Yoshihiko Ooka, Hiroshi Ohyama, Ritsuko Yokouchi, Naho Sato, Hitoshi Mochizuki, Masao Omata. The incidence of all organ malignancies and overall survival of patient with sustained virological response of HCV-comparable to SMR (standardized mortality ratio) of Japan general population. Hepatology International 2023; 17(3): 562 doi: 10.1007/s12072-023-10495-z
|
44 |
Clodoveo Ferri, Jordan J Feld, Mark Bondin, Patrice Cacoub. Expert Opinion on Managing Chronic HCV in Patients with Non-Hodgkin Lymphoma and other Extrahepatic Malignancies. Antiviral Therapy 2018; 23(1_suppl): 23 doi: 10.3851/IMP3250
|
45 |
Maya Balakrishnan, Matthew T. Glover, Fasiha Kanwal. Hepatitis C and Risk of Nonhepatic Malignancies. Clinics in Liver Disease 2017; 21(3): 543 doi: 10.1016/j.cld.2017.03.009
|
46 |
Shuo Wang, Xiao-Zhong Guo, Shi-Xue Xu, Xing-Shun Qi. Risk and treatment of non-hepatic cancers in patients with cirrhosis. World Chinese Journal of Digestology 2020; 28(15): 655 doi: 10.11569/wcjd.v28.i15.655
|
47 |
Chun-Wei Chen, Jur- Shan Cheng, Tsung-Hsing Chen, Chia-Jung Kuo, Hsin-Ping Ku, Rong-Nan Chien, Ming-Ling Chang. Different metabolic associations of hepatitis C with colon and rectal cancers: A 9-year nationwide population-based cohort study. Clinical Colorectal Cancer 2024; doi: 10.1016/j.clcc.2024.08.005
|
48 |
Sirio Fiorino, Salomone Di Saverio, Paolo Leandri, Andrea Tura, Chiara Birtolo, Mauro Silingardi, Dario de Biase, Eli Avisar. The Role of Matricellular Proteins and Tissue Stiffness in Breast Cancer: A Systematic Review. Future Oncology 2018; 14(16): 1601 doi: 10.2217/fon-2017-0510
|
49 |
Kazuhito Kawata, Masanori Atsukawa, Kazuyoshi Ohta, Takeshi Chida, Hidenao Noritake, Taeang Arai, Katsuhiko Iwakiri, Satoshi Yasuda, Hidenori Toyoda, Tomomi Okubo, Atsushi Hiraoka, Tsunamasa Watanabe, Haruki Uojima, Akito Nozaki, Joji Tani, Asahiro Morishita, Fujito Kageyama, Yuzo Sasada, Masamichi Nagasawa, Masahiro Matsushita, Tatsuki Oyaizu, Shigeru Mikami, Tadashi Ikegami, Hiroshi Abe, Kentaro Matsuura, Yasuhito Tanaka, Akihito Tsubota. Mac‐2‐binding protein glycan isomer predicts all malignancies after sustained virological response in chronic hepatitis C. Hepatology Communications 2022; 6(8): 1855 doi: 10.1002/hep4.1941
|
50 |
D. A. Lioznov, M. S. Nozhkin, O. V. Gorchakova, T. V. Antonova. Characteristics of HCV infection in oncohematological patients. Journal Infectology 2020; 12(1): 91 doi: 10.22625/2072-6732-2020-12-1-91-95
|
51 |
Ryan M. Kwok, Tram T. Tran. Management of Cirrhotic Patients After Successful HCV Eradication. Current Treatment Options in Gastroenterology 2017; 15(2): 305 doi: 10.1007/s11938-017-0134-2
|
52 |
Sven H. Loosen, David Schöler, Mark Luedde, Johannes Eschrich, Tom Luedde, Karel Kostev, Christoph Roderburg. Differential role of chronic liver diseases on the incidence of cancer: a longitudinal analysis among 248,224 outpatients in Germany. Journal of Cancer Research and Clinical Oncology 2023; 149(7): 3081 doi: 10.1007/s00432-022-04198-5
|
53 |
Haiping Chen, Pei Du, Tianyao Yang, Xueyuan Xu, Tianyang Cui, Yuhang Dai. Hepatitis C virus infection is associated with high risk of breast cancer: a pooled analysis of 68,014 participants. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1274340
|
54 |
Zuzana Vojtechova, Ruth Tachezy. The Role of miRNAs in Virus-Mediated Oncogenesis. International Journal of Molecular Sciences 2018; 19(4): 1217 doi: 10.3390/ijms19041217
|
55 |
Ameer Abutaleb, Shyam Kottilil, Elana Rosenthal. Viral Infections of Humans. 2022; : 1 doi: 10.1007/978-1-4939-9544-8_64-1
|
56 |
Tung‐Hung Su, Tai‐Chung Tseng, Chun‐Jen Liu, Shih‐Wan Chou, Chen‐Hua Liu, Hung‐Chih Yang, Pei‐Jer Chen, Ding‐Shinn Chen, Chi‐Ling Chen, Jia‐Horng Kao. Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer. International Journal of Cancer 2020; 147(3): 901 doi: 10.1002/ijc.32840
|
57 |
Ameer Abutaleb, Jose Antonio Almario, Saleh Alghsoon, Ji Ae Yoon, Kate Gheysens, Shyam Kottilil, Eleanor Wilson. Higher Levels of Fibrosis in a Cohort of Veterans with Chronic Viral Hepatitis are Associated with Extrahepatic Cancers. Journal of Clinical and Experimental Hepatology 2021; 11(2): 195 doi: 10.1016/j.jceh.2020.08.001
|
58 |
Esma Bilajac, Lejla Mahmutović, Kenneth Lundstrom, Una Glamočlija, Jasmin Šutković, Abas Sezer, Altijana Hromić-Jahjefendić. Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis. Viruses 2022; 14(10): 2105 doi: 10.3390/v14102105
|
59 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 1671 doi: 10.1007/978-3-319-26956-6_94
|
60 |
Daniel Segna, Jean-François Dufour. Other Extrahepatic Manifestations of Hepatitis C Virus Infection (Pulmonary, Idiopathic Thrombocytopenic Purpura, Nondiabetes Endocrine Disorders). Clinics in Liver Disease 2017; 21(3): 607 doi: 10.1016/j.cld.2017.03.014
|
61 |
Johad Khoury, George Nassar, Rimma Kramsky, Tarek Saadi. Extrahepatic Malignancies After Treatment with Direct Antiviral Agents for Chronic HCV Infection. Journal of Gastrointestinal Cancer 2020; 51(2): 584 doi: 10.1007/s12029-019-00293-y
|
62 |
Yung-Rung Lai, Ya-Lan Chang, Chiu-Hsiang Lee, Tung-Han Tsai, Kuang-Hua Huang, Chien-Ying Lee. Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort Study. Cancers 2022; 14(3): 583 doi: 10.3390/cancers14030583
|
63 |
Charlotte Lybeck, Daniel Bruce, Scott M. Montgomery, Soo Aleman, Ann‐Sofi Duberg. Risk of extrahepatic cancer in a nationwide cohort of hepatitis C virus infected persons treated with direct‐acting antivirals. GastroHep 2021; 3(3): 185 doi: 10.1002/ygh2.456
|
64 |
Ahmed Arafa, Ehab S. Eshak, Tarek A. Abdel Rahman, Manal M. Anwar. Hepatitis C virus infection and risk of pancreatic cancer: A meta-analysis. Cancer Epidemiology 2020; 65: 101691 doi: 10.1016/j.canep.2020.101691
|
65 |
Fu-Hsiung Su, Chyi-Huey Bai, Thi Nga Le, Chih-Hsin Muo, Shih-Ni Chang, Arlene Te, Fung-Chang Sung, Chih-Ching Yeh. Patients With Chronic Hepatitis C Virus Infection Are at an Increased Risk of Colorectal Cancer: A Nationwide Population-Based Case-Control Study in Taiwan. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.561420
|
66 |
Stanislas Pol, Lucia Parlati, Michel Jadoul. Hepatitis C virus and the kidney. Nature Reviews Nephrology 2019; 15(2): 73 doi: 10.1038/s41581-018-0081-8
|
67 |
Gema Lledó, Laura Benítez-Gutiérrez, Ana Arias, Silvia Requena, Valentín Cuervas-Mons, Carmen de Mendoza. Benefits of Hepatitis C Cure With Antivirals: Why Test and Treat?. Future Microbiology 2019; 14(5): 425 doi: 10.2217/fmb-2019-0041
|
68 |
Keerthana Raja, Sembiyaa Arumugam, Sheik S.S.J. Ahmed, Ramakrishnan Veerabathiran. Oncogenic Viruses. 2023; : 197 doi: 10.1016/B978-0-12-824152-3.00006-8
|